跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 112 条关于
“CXCR3”
全部
112
临床试验
55
药物
42
机构
0
资讯
15
去年
Single-Cell Analysis Reveals BRCA1 Mutation Drives Distinct Tumor Microenvironments in Triple-Negative Breast Cancer
24天前
Cellenkos Receives FDA Fast Track Designation for CK0803 in Amyotrophic Lateral Sclerosis
9个月前
Cellenkos' CK0804 Regulatory T Cell Therapy Shows Promise in JAK Inhibitor-Resistant Myelofibrosis
3个月前
Memory B Cells Reveal Blueprint for Nasal Vaccines That Could Stop Respiratory Infections at Their Entry Point
去年
Cellenkos' Novel Off-The-Shelf Treg Cell Therapy Demonstrates Promising Results in ALS Clinical Study
4个月前
NIVIPIT Trial Demonstrates Reduced Toxicity with Intratumoral Anti-CTLA4 in Metastatic Melanoma
5个月前
Edesa Biotech Prepares Phase 2 Vitiligo Trial for Mid-2026 Launch Following Promising ARDS Results
去年
Exicure Secures Australian Patent for Novel Cancer Treatment Targeting CXCR4 and GPCRx
6个月前
Pentixapharm Receives FDA Approval for CXCR4-Targeted Radiotheranostic Program in Blood Cancers
去年
Pentixapharm Pivots Clinical Strategy to Focus on CXCR4-Targeted Theranostic Oncology Platform
第 1 页,共 2 页
上一页
下一页